Original Research
Published in:
Volume 4 / Year 2015 / Issue 1
Volume 4 / Year 2015 / Issue 1
Payer and physician evidence and discount requirements for biosimilars in three Latin American countries
Author(s): 1 Erik Sandorff, MA, MBA, André Vidal Pinheiro, PhD, Associate Professor Valderilio Feijó Azevedo, MD, PhD, MSc, Daniele Severi Bruni, MPhil, Ronald Halbert, MD, MPH
Page: 11-6
Page: 11-6
Study objectives: In Latin America, many governments have attempted to address biosimilar safety and efficacy concerns by developing abbreviated regulatory pathways to increase access while controlling quality. This study explores… Read More »
What pricing and reimbursement policies to use for off-patent biologicals? – Results from the EBE 2014 biological medicines policy survey
Author(s): European Biopharmaceutical Enterprises
Page: 17-24
Page: 17-24
Objective: One of the questions that the advent of biosimilars raises is whether the different nature of biological medicines would also imply the need for a different policy approach by… Read More »